Breaking News
Sort by:
Date
Top Post
SNIPR Biome Reports Positive Clinical Interim Results for Groundbreaking, First-in-Human, CRISPR-based Microbial Gene Therapy
SNIPR Biome, the company pioneering CRISPR microbial gene therapy, has announced positive interim clinical results […]
RVAC Medicines, a CBC-Incubated mRNA Platform Company, Raises US$140 Million to Expand R&D and Manufacturing Capacity
RVAC Medicines Pte. Ltd. (“RVAC”), an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC […]
ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets
ENSEM Therapeutics Inc. (ENSEM), a Boston-based biotechnology company focusing on high value and difficult-to-drug oncology targets, […]
- Cumulus Neuroscience Completes Patient Enrollment for Pivotal CNS-101 Early-Stage Alzheimer’s Dementia Validation Trial Read more
- Cartography Biosciences Expands Scientific Advisory Board with Leading Antibody and Bi-specific Experts Read more
- Mission Bio Launches Tapestri v3 to Rapidly Accelerate Rare Cell Detection Applications for Translational Research and Precision Therapeutics Read more
- Ostentus Therapeutics and City of Hope to Continue Studies of Novel OST Natural Products for Treatment of Leukemia and Other Cancers Read more
- Cellular Origins launches Constellation, its Configurable Robotic Platform to Enable Scalable Manufacture of Advanced Therapies Read more